Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura Gault, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 62565
Gdynia, Poland
- Site Reference Id/investigator# 62563
Poznan, Poland
- Site Reference Id/investigator# 62562
Szczecin, Poland
- Site Reference Id/investigator# 60945
Kazan', Russia
- Site Reference Id/investigator# 60955
Kazan', Russia
- Site Reference Id/investigator# 60954
Kirov, Russia
- Site Reference Id/investigator# 60951
Moscow, Russia
- Site Reference Id/investigator# 60959
Moscow, Russia
- Site Reference Id/investigator# 60946
Novosibirsk, Russia
- Site Reference Id/investigator# 60947
Saint Petersburg, Russia
- Site Reference Id/investigator# 60949
Saint Petersburg, Russia
- Site Reference Id/investigator# 60952
Saint Petersburg, Russia
- Site Reference Id/investigator# 60958
Saint Petersburg, Russia
- Site Reference Id/investigator# 60950
Saratov, Russia
- Site Reference Id/investigator# 60911
Belville, South Africa
- Site Reference Id/investigator# 76073
Cape Town, South Africa
- Site Reference Id/investigator# 60912
George, South Africa
- Site Reference Id/investigator# 60910
Johannesburg, South Africa
- Site Reference Id/investigator# 60909
Donetsk, Ukraine
- Site Reference Id/investigator# 60906
Kiev, Ukraine
- Site Reference Id/investigator# 60905
Poltava, Ukraine
- Site Reference Id/investigator# 60960
Bath, United Kingdom
- Site Reference Id/investigator# 60963
Blackburn, United Kingdom
- Site Reference Id/investigator# 60962
Glasgow, United Kingdom
- Site Reference Id/investigator# 60961
London, United Kingdom
- Site Reference Id/investigator# 56503
Delray Beach, Florida, United States
- Site Reference Id/investigator# 56518
Tampa, Florida, United States
- Site Reference Id/investigator# 56514
West Palm Beach, Florida, United States
- Site Reference Id/investigator# 62611
Elk Grove Village, Illinois, United States
- Site Reference Id/investigator# 56506
Staten Island, New York, United States
- Site Reference Id/investigator# 82994
Jenkintown, Pennsylvania, United States
- Site Reference Id/investigator# 77636
Wichita Falls, Texas, United States
- Site Reference Id/investigator# 56504
Bennington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2012
- Primary completion
- 30 Nov 2013
- Completion
- 30 Nov 2013
- Last update posted
- 19 Nov 2014
- Registered enrollment
- 438
- Registry id
- NCT01527916
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.